Health
newsGP – Novavax confirms efficacy against emerging coronavirus variants – RACGP
New data on Australia’s third vaccine candidate shows it is highly effective against most COVID-19 variants, which may prove crucial as production bottlenecks force…
News
New data on Australia’s third vaccine candidate shows it is highly effective against most COVID-19 variants, which may prove crucial as production bottlenecks force delays among other options.
Interim results Novavaxs phase 3 clinical trials show it has 95.6% efficacy against the main COVID strain.
The interim results from one arm of Novavax’s phase 3 clinical trials show it has 95.6% efficacy against the main coronavirus strain – and is almost as effective against the concerning UK variant,…
-
Noosa News22 hours agoHow Lily Steele-Park took her rapist to court and won
-
Noosa News23 hours agoE-biker charged with riding dangerously, assaulting cop
-
General21 hours agoBrick portico a relic of ‘prestigious’ Horton College in northern midlands
-
Business16 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today